ID   PPR3C_HUMAN             Reviewed;         317 AA.
AC   Q9UQK1; B2R7X0; O95686;
DT   01-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   12-APR-2017, entry version 111.
DE   RecName: Full=Protein phosphatase 1 regulatory subunit 3C;
DE   AltName: Full=Protein phosphatase 1 regulatory subunit 5;
DE            Short=PP1 subunit R5;
DE   AltName: Full=Protein targeting to glycogen;
DE            Short=PTG;
GN   Name=PPP1R3C {ECO:0000312|HGNC:HGNC:9293};
GN   Synonyms=PPP1R5 {ECO:0000312|EMBL:CAA77082.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:CAA77082.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND INTERACTION WITH PPP1CC.
RC   TISSUE=Gall bladder {ECO:0000269|PubMed:8985175};
RX   PubMed=8985175; DOI=10.1016/S0014-5793(96)01357-9;
RA   Doherty M.J., Young P.R., Cohen P.T.W.;
RT   "Amino acid sequence of a novel protein phosphatase 1 binding protein
RT   (R5) which is related to the liver- and muscle-specific glycogen
RT   binding subunits of protein phosphatase 1.";
RL   FEBS Lett. 399:339-343(1996).
RN   [2] {ECO:0000312|EMBL:AAD33215.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10222257; DOI=10.1006/bbrc.1999.0614;
RA   Permana P.A., Luczy-Bachman G., Bogardus C.;
RT   "Protein targeting to glycogen/PPP1R5: screening of coding and
RT   flanking genomic regions for polymorphisms and association analysis
RT   with insulin action in Pima Indians.";
RL   Biochem. Biophys. Res. Commun. 258:184-186(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Retina;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5] {ECO:0000312|EMBL:CAH69995.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6] {ECO:0000312|EMBL:CAD97641.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000312|EMBL:AAH12625.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle {ECO:0000312|EMBL:AAH12625.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8] {ECO:0000305}
RP   INTERACTION WITH EPM2A, AND MUTAGENESIS OF VAL-85; PHE-87; ASP-247 AND
RP   ASP-250.
RX   PubMed=14532330; DOI=10.1093/hmg/ddg340;
RA   Fernandez-Sanchez M.E., Criado-Garcia O., Heath K.E.,
RA   Garcia-Fojeda B., Medrano-Fernandez I., Gomez-Garre P., Sanz P.,
RA   Serratosa J.M., Rodriguez de Cordoba S.;
RT   "Laforin, the dual-phosphatase responsible for Lafora disease,
RT   interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1
RT   that enhances glycogen accumulation.";
RL   Hum. Mol. Genet. 12:3161-3171(2003).
RN   [9]
RP   UBIQUITINATION, AND INTERACTION WITH EPM2A.
RX   PubMed=18070875; DOI=10.1074/jbc.M708712200;
RA   Worby C.A., Gentry M.S., Dixon J.E.;
RT   "Malin decreases glycogen accumulation by promoting the degradation of
RT   protein targeting to glycogen (PTG).";
RL   J. Biol. Chem. 283:4069-4076(2008).
RN   [10]
RP   VARIANT SER-249.
RX   PubMed=21738631; DOI=10.1371/journal.pone.0021294;
RA   Guerrero R., Vernia S., Sanz R., Abreu-Rodriguez I., Almaraz C.,
RA   Garcia-Hoyos M., Michelucci R., Tassinari C.A., Riguzzi P., Nobile C.,
RA   Sanz P., Serratosa J.M., Gomez-Garre P.;
RT   "A PTG variant contributes to a milder phenotype in Lafora disease.";
RL   PLoS ONE 6:E21294-E21294(2011).
CC   -!- FUNCTION: Acts as a glycogen-targeting subunit for PP1 and
CC       regulates its activity. Activates glycogen synthase, reduces
CC       glycogen phosphorylase activity and limits glycogen breakdown.
CC       Dramatically increases basal and insulin-stimulated glycogen
CC       synthesis upon overexpression in a variety of cell types.
CC       {ECO:0000250|UniProtKB:Q7TMB3, ECO:0000269|PubMed:8985175}.
CC   -!- SUBUNIT: Interacts with PPP1CC catalytic subunit of PP1 and
CC       associates with glycogen. Forms complexes with glycogen
CC       phosphorylase, glycogen synthase and phosphorylase kinase which is
CC       necessary for its regulation of PP1 activity. Also interacts with
CC       EPM2A/laforin. {ECO:0000250|UniProtKB:Q7TMB3,
CC       ECO:0000269|PubMed:14532330, ECO:0000269|PubMed:18070875,
CC       ECO:0000269|PubMed:8985175}.
CC   -!- INTERACTION:
CC       O95278:EPM2A; NbExp=5; IntAct=EBI-2506727, EBI-2506661;
CC       P62140:PPP1CB; NbExp=5; IntAct=EBI-2506727, EBI-352350;
CC   -!- DOMAIN: The N-terminal region is required for binding to PP1, the
CC       central region is required for binding to glycogen and the C-
CC       terminal region is required for binding to glycogen phosphorylase,
CC       glycogen synthase and phosphorylase kinase.
CC       {ECO:0000250|UniProtKB:Q7TMB3}.
CC   -!- PTM: Ubiquitinated by NHLRC1/malin in a EPM2A/laforin-dependent
CC       manner. {ECO:0000269|PubMed:18070875}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD33215.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; Y18207; CAA77082.1; -; mRNA.
DR   EMBL; AF110824; AAD33215.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AK313149; BAG35967.1; -; mRNA.
DR   EMBL; BX537399; CAD97641.1; -; mRNA.
DR   EMBL; AL359986; CAH69995.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW50107.1; -; Genomic_DNA.
DR   EMBL; BC012625; AAH12625.1; -; mRNA.
DR   CCDS; CCDS7416.1; -.
DR   RefSeq; NP_005389.1; NM_005398.6.
DR   UniGene; Hs.303090; -.
DR   UniGene; Hs.744999; -.
DR   ProteinModelPortal; Q9UQK1; -.
DR   SMR; Q9UQK1; -.
DR   BioGrid; 111500; 18.
DR   IntAct; Q9UQK1; 6.
DR   MINT; MINT-6783827; -.
DR   STRING; 9606.ENSP00000238994; -.
DR   CAZy; CBM21; Carbohydrate-Binding Module Family 21.
DR   iPTMnet; Q9UQK1; -.
DR   PhosphoSitePlus; Q9UQK1; -.
DR   BioMuta; PPP1R3C; -.
DR   DMDM; 146325084; -.
DR   PaxDb; Q9UQK1; -.
DR   PeptideAtlas; Q9UQK1; -.
DR   PRIDE; Q9UQK1; -.
DR   DNASU; 5507; -.
DR   Ensembl; ENST00000238994; ENSP00000238994; ENSG00000119938.
DR   GeneID; 5507; -.
DR   KEGG; hsa:5507; -.
DR   UCSC; uc001kho.4; human.
DR   CTD; 5507; -.
DR   DisGeNET; 5507; -.
DR   GeneCards; PPP1R3C; -.
DR   HGNC; HGNC:9293; PPP1R3C.
DR   HPA; HPA027041; -.
DR   MIM; 602999; gene.
DR   neXtProt; NX_Q9UQK1; -.
DR   OpenTargets; ENSG00000119938; -.
DR   PharmGKB; PA33653; -.
DR   eggNOG; KOG3986; Eukaryota.
DR   eggNOG; ENOG4111FT1; LUCA.
DR   GeneTree; ENSGT00530000062978; -.
DR   HOGENOM; HOG000026799; -.
DR   HOVERGEN; HBG052744; -.
DR   InParanoid; Q9UQK1; -.
DR   KO; K07189; -.
DR   OMA; PLKSCLN; -.
DR   OrthoDB; EOG091G0GB5; -.
DR   PhylomeDB; Q9UQK1; -.
DR   TreeFam; TF105537; -.
DR   Reactome; R-HSA-3322077; Glycogen synthesis.
DR   Reactome; R-HSA-3785653; Myoclonic epilepsy of Lafora.
DR   ChiTaRS; PPP1R3C; human.
DR   GeneWiki; PPP1R3C; -.
DR   GenomeRNAi; 5507; -.
DR   PRO; PR:Q9UQK1; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000119938; -.
DR   CleanEx; HS_PPP1R3C; -.
DR   Genevisible; Q9UQK1; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0019903; F:protein phosphatase binding; ISS:UniProtKB.
DR   GO; GO:0019888; F:protein phosphatase regulator activity; IEA:InterPro.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; TAS:ProtInc.
DR   GO; GO:0005978; P:glycogen biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0005977; P:glycogen metabolic process; ISS:UniProtKB.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR005036; CBM21_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR017434; Pase-1_reg-su_3B/C/D_met.
DR   InterPro; IPR030683; PP1_3C.
DR   Pfam; PF03370; CBM_21; 1.
DR   PIRSF; PIRSF038207; PP1_GT_animal; 1.
DR   PIRSF; PIRSF500813; PP1_PTG; 1.
DR   PROSITE; PS51159; CBM21; 1.
PE   1: Evidence at protein level;
KW   Carbohydrate metabolism; Complete proteome; Glycogen metabolism;
KW   Polymorphism; Reference proteome; Ubl conjugation.
FT   CHAIN         1    317       Protein phosphatase 1 regulatory subunit
FT                                3C.
FT                                /FTId=PRO_0000285927.
FT   DOMAIN      149    257       CBM21. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00491}.
FT   REGION      141    263       Interaction with EPM2A.
FT                                {ECO:0000269|PubMed:14532330}.
FT   MOTIF        84     87       PP1-binding motif.
FT   VARIANT     109    109       A -> S (in dbSNP:rs7089948).
FT                                /FTId=VAR_059775.
FT   VARIANT     249    249       N -> S (found in a patient with
FT                                progressive myoclonic epilepsy type 2
FT                                also carrying two mutations in EPM2B;
FT                                dbSNP:rs373998228).
FT                                {ECO:0000269|PubMed:21738631}.
FT                                /FTId=VAR_067339.
FT   MUTAGEN      85     85       V->A: No effect on interaction with
FT                                EPM2A; when associated with A-87.
FT                                {ECO:0000269|PubMed:14532330}.
FT   MUTAGEN      87     87       F->A: No effect on interaction with
FT                                EPM2A; when associated with A-85.
FT                                {ECO:0000269|PubMed:14532330}.
FT   MUTAGEN     247    247       D->A: No interaction with EPM2A; when
FT                                associated with A-250.
FT                                {ECO:0000269|PubMed:14532330}.
FT   MUTAGEN     250    250       D->A: No interaction with EPM2A; when
FT                                associated with A-247.
FT                                {ECO:0000269|PubMed:14532330}.
SQ   SEQUENCE   317 AA;  36445 MW;  FBFD6DE015F9AB2D CRC64;
     MSCTRMIQVL DPRPLTSSVM PVDVAMRLCL AHSPPVKSFL GPYDEFQRRH FVNKLKPLKS
     CLNIKHKAKS QNDWKCSHNQ AKKRVVFADS KGLSLTAIHV FSDLPEEPAW DLQFDLLDLN
     DISSALKHHE EKNLILDFPQ PSTDYLSFRS HFQKNFVCLE NCSLQERTVT GTVKVKNVSF
     EKKVQIRITF DSWKNYTDVD CVYMKNVYGG TDSDTFSFAI DLPPVIPTEQ KIEFCISYHA
     NGQVFWDNND GQNYRIVHVQ WKPDGVQTQM APQDCAFHQT SPKTELESTI FGSPRLASGL
     FPEWQSWGRM ENLASYR
//
